Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symtuza vs Biktarvy microRNA and Weight Gain in HIV
NCT05463783Phase 4Unknown
- Sponsor
- East Carolina University
- Start
- Mar 2023
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tenofovir alafenamide in human immunodeficiency virus infection (HIV), sponsored by East Carolina University. Status: unknown.
02
Drugs
tenofovir alafenamide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT05463783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05463783.